Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT04367467
Eligibility Criteria:
Inclusion Criteria:
* Adult patients age 18 years or older
* Diagnosed with any solid organ cancer
* Planned to receive a PARP inhibitor (olaparib, niraparib, rucaparib, veliparib, or talazoparib)
* Able to consent to study related procedures
* If unable to give informed consent, must have healthcare proxy or legally authorized representative
* Fluent in conversational English (Informed Consent form currently in English language)
Exclusion Criteria:
* Patients who will not receive ongoing cancer care at Penn Medicine
* Major psychiatric illness or cognitive impairment that in the judgment of the study investigators or study staff would preclude study participation
* Any patients who are unable to comply with the study procedures as determined by the study investigators or study staff
* Patients on dialysis
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04367467
Study Brief:
Protocol Section:
NCT04367467